Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Vasculitis Treatment Update

Keck School of Medicine of USC

K. Ruddy

Management of Raynaud’s Phenomenon

John D. Pauling

ECTRIMS 2024 Insights: Real-World Evidence on Infection-Related Hosp…

Afagh Garjani

ECTRIMS 2024 Insights: Increased Brain Age Is Associated With Clinic…

Lonneke Bos

New Therapeutic Options for the Management of the Hospitalized Patie…

28th Annual Heart Failure 2024: An Update on Therapy

U. Elkayam

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Contrast Nephropathy

ARCH Advanced Revascularization Symposium

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Multiple Sclerosis Treatment

ZINCARE

M. Chomba

Health Disparities in SLE

Hospital for Special Surgery

J. Yazdany

Hurdles on the Way to Disease Modification in Lupus

ARTHROS

M. Petri

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson